This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Seamless data sharing between clinical teams and medicalscience liaisons, for example, could greatly influence clinical trial site selection and ensure more coordinated engagement. This will force a shift in how companies think about incentive comp,” explains Dan Rizzo, VP, global business consulting leader. “In
Engagement with Healthcare Professionals (HCPs) Medical affairs’ growing role in broader HCP engagement necessitates tracking interaction frequency, engagement quality, and HCP satisfaction–which may be beyond the capabilities of many medical affairs organizations. Measuring medical affairs success is challenging.
sales, medicalscience liaisons, etc.). Furthermore, all patients, and especially those who are most vulnerable to severe outcomes from the virus, may be less willing or able to travel to the doctor’s office for non-COVID-related medical concerns.
Takeda Connect provides oncologists with information about their Key Account Manager and MedicalScience Liaison, alongside direct access at the click of a button. Beyond personalising content, creating a tailored channel experience is also vitally important. While field force teams in areas of the world such as the U.S.,
They will be located in a specific geographical location, but it is likely that they will specialize in certain products or medical areas. They are medical agents (i.e., supplier agents) and are responsible for marketing and selling medical products and services to healthcare professionals.
A recent Sermo survey indicated that nearly two-thirds of responders changed their perception of medications or treatment options based on information obtained on social media. Fifty percent of responders said they changed prescriptions because of social media information.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content